RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the spectrum of breast cancer. The current clinical guidelines propose treatment strategies involving cytotoxic agents like epirubicin or paclitaxel. However, the emergence of acquired resistance frequently precipi...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Fengxu Lv, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, Feifei Li
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Elsevier 2024-02-01
Loạt:	Neoplasia: An International Journal for Oncology Research
Những chủ đề:	Triple negative breast cancer Chemoresistance Cancer stem cells RUNX2 TGF-β
Truy cập trực tuyến:	http://www.sciencedirect.com/science/article/pii/S1476558624000046

Những quyển sách tương tự

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
Bằng: Wentao Si, et al.
Được phát hành: (2022-11-01)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
Bằng: Natalia B. Fernández, et al.
Được phát hành: (2023-01-01)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
Bằng: Bradley A. Hancock, et al.
Được phát hành: (2019-08-01)

Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer
Bằng: Liang Gao, et al.
Được phát hành: (2021-08-01)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
Bằng: Guoyu Wu, et al.
Được phát hành: (2022-04-01)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
Bằng: Alexander H. Chung, et al.
Được phát hành: (2019-02-01)

DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition
Bằng: Jianbo Zheng, et al.
Được phát hành: (2018-04-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
Bằng: Meng Wang, et al.
Được phát hành: (2021-10-01)

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
Bằng: Anuradha Illendula, et al.
Được phát hành: (2016-06-01)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
Bằng: Margarite D. Matossian, et al.
Được phát hành: (2019-03-01)

Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer
Bằng: Adam Hermawan, et al.
Được phát hành: (2019-12-01)

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
Bằng: Adiba S. Khan, et al.
Được phát hành: (2023-02-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
Bằng: Shen-Jun Yuan, et al.
Được phát hành: (2019-10-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
Bằng: Ling Wang, et al.
Được phát hành: (2018-07-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Bằng: Hitesh Kumar, et al.
Được phát hành: (2023-12-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
Bằng: Liu C, et al.
Được phát hành: (2020-12-01)

A clinicopathologic study of triple negative breast cancer
Bằng: Vandana L Gaopande, et al.
Được phát hành: (2015-01-01)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
Bằng: Nicholas R. Hum, et al.
Được phát hành: (2022-07-01)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
Bằng: Andrew Sulaiman, et al.
Được phát hành: (2021-10-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
Bằng: Alaa M. Ghallab, et al.
Được phát hành: (2022-04-01)

Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer
Bằng: Lei Di, et al.
Được phát hành: (2019-03-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
Bằng: Weiguang Liu, et al.
Được phát hành: (2019-09-01)

RUNX regulated immune-associated genes predicts prognosis in breast cancer
Bằng: Jingyue Fu, et al.
Được phát hành: (2022-08-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
Bằng: Xi Liu, et al.
Được phát hành: (2024-02-01)

CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer
Bằng: Jingchao Wang, et al.
Được phát hành: (2024-06-01)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
Bằng: Dayanidhi Raman, et al.
Được phát hành: (2022-12-01)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
Bằng: Ammar Said Suliman, et al.
Được phát hành: (2021-01-01)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
Bằng: Yen-Dun Tony Tzeng, et al.
Được phát hành: (2018-11-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
Bằng: Weiguang Liu, et al.
Được phát hành: (2019-07-01)

Current approaches in treatment of triple-negative breast cancer
Bằng: Hanan Ahmed Wahba, et al.
Được phát hành: (2015-06-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
Bằng: Mahdi Aghili, et al.
Được phát hành: (2013-08-01)

Platinum chemotherapy for early triple-negative breast cancer
Bằng: Sofia RE. Mason, et al.
Được phát hành: (2024-06-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
Bằng: Srijan Basu, et al.
Được phát hành: (2023-11-01)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
Bằng: Omran Saifi, et al.
Được phát hành: (2022-04-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
Bằng: Yueh-Te Lin, et al.
Được phát hành: (2022-10-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
Bằng: Elizabeth R. Berger, et al.
Được phát hành: (2021-08-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
Bằng: Magdalena Niedolistek, et al.
Được phát hành: (2020-04-01)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
Bằng: Lisa Agnello, et al.
Được phát hành: (2023-07-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
Bằng: Mohammed Amrallah A., et al.
Được phát hành: (2021-05-01)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
Bằng: Yi-Fen Chiang, et al.
Được phát hành: (2023-01-01)